Search
for
Sort by
Research 511–540 of 1000+
- Serum androgen levels and their relationship to pattern and severity of hair growth in hirsute women presenting at private centre in Hyderabad
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Phototherapy of androgenetic alopecia with low level narrow band 655-nm red light and 780-nm infrared light
- Reply
- Platelet Immune Interactions, Lifespan, and Senescence
- Iraqi Women with Hirsutism, Clinical and Biochemical Characteristics: Retrospective Study
- Efficacy and safety of diode laser for facial hair reduction in hirsutism—a clinico-trichoscopic evaluation
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Role of Lactoferrin in Chronic Telgon Effluvium
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- ALOPECIA AREATA-A CLINICAL ANALYSIS
- The lowest effective dose of botulinum toxin in detrusor sphincter dyssynergia
- SUMMARIES OF PAPERS
- Effectiveness and safety of triple-diode laser with or without adjunctive topical eflornithine in female hirsutism
- Generalised Gingival Fibromatosis and Hypertrichosis: A Rare Case of Syndromic Presentation
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- Update: baricitinib for alopecia areata
- Management of women with hirsutism in Kosovo
- The prevalence of thyroid function test abnormalities and serum thyroid autoantibodies in vitiligo and alopecia areata patients in Saudi Arabian population
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Management of Hirsutism Associated With Obese PCOD - A Case Report
- A review on follicular targeting for the treatment of hirsutism
- Folliculotropic mycosis fungoides
- Anxiety and Hair Restoration Surgery
- Hair Disorders
- Hair Loss in Children
- Issue Information
- The eyelash comes to the fore
- Pramipexole
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment